Phoenix Holdings Ltd. Syndax Pharmaceuticals Inc Transaction History

Phoenix Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	BUY	$14.84 - $22.15 $2.72 Million - $4.06 Million	183,500 Added 53.6%	525,856 $9.14 Million
Q4 2021 Feb 07, 2022	BUY	$15.23 - $22.47 $2.02 Million - $2.97 Million	132,356 Added 63.03%	342,356 $7.49 Million
Q3 2021 Oct 27, 2021	BUY	$13.87 - $19.8 $1.39 Million - $1.98 Million	100,000 Added 90.91%	210,000 $4.01 Million
Q2 2021 Aug 10, 2021	BUY	$13.42 - $25.18 $1.48 Million - $2.77 Million	110,000 New	110,000 $1.89 Million

228

88.4M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.